ICICI Prudential Nifty Pharma Index Fund Regular Growth
Medium
Risk
Equity
Index Fund
+
0.00
%
0.00
%
3Y annualised
+
0.29
%
0.29
%
1D
1M
6M
1Y
3Y
All
Fund size
33
NAV:
Mar 7, 2024
14.6952
Sector
Tech
Type
Equity
Launched
Dec 2022
Min Investment
1000
Expense Ratio
1
Risk
Medium
Portfolio allocation
Top 10 Holdings
% Value
Sun Pharmaceuticals Industries Ltd
25.15
%
Dr Reddy's Laboratories Ltd
12.24
%
Cipla Ltd
11.64
%
Divi's Laboratories Ltd
7.68
%
Lupin Ltd
5.96
%
Aurobindo Pharma Ltd
5.31
%
Alkem Laboratories Ltd
4.12
%
Torrent Pharmaceuticals Ltd
3.8
%
Zydus Lifesciences Ltd
3.16
%
Ipca Laboratories Ltd
2.47
%
Expense ratio, exit load and tax
Expense Ratio:
1
%
Inclusive of GST
Exit load
No exit loads
Tax implication
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
Fund house & investment objective
ICICI Prudential Nifty Pharma Index Fund Regular Growth
More details
Investment objective
The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
Scheme Information Document
Mutual Fund investments are subject to market risks. Read all scheme-related documents carefully. Past performance is not an indicator of future returns.
Calculate returns
One-time
Monthly SIP
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
* Returns are calculated as per lifetime average per annum returns of the fund.
Calculate returns
Monthly SIP
One-time
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
